The Outlook for Vaccines, Variants and Elusive Herd Immunity

As COVID-19 and its’ variants continue to cause concern in the U.S. and around the world, I thought you would be interested in hearing what Raymond James Biotechnology Analyst Steve Seedhouse, Ph.D. has to say about the future. I invite you to take 16 minutes to listen to the latest edition of Raymond James’ podcast For What It’s Worth. Of course if you have any questions, I welcome your call or email.

https://www.raymondjames.com/commentary-and-insights/lifestyle-technology/2021/08/06/the-outlook-for-vaccines-variants-and-elusive-herd-immunity